OneMedNet (ONMD) insider invests $1,000,000 in new share subscription

Rhea-AI Filing Summary

OneMedNet Corp reported that director and 10% owner Thomas Kosasa purchased 1,449,275 shares of common stock on July 30, 2026. The $1,000,000 investment was made through a subscription agreement, with the shares priced at $0.69 each, based on the volume-weighted average price for the 10 trading days immediately prior to the purchase date. Following the transaction, he directly owns 18,538,150 shares.

Insider Trade Summary

Net Buyer: 1,449,275 shares

Net Buy 1 txn

Insider Kosasa Thomas

Role Director, 10% Owner

Bought 1,449,275 shs ($1000K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1, F2	1,449,275	$0.69	$1000K

Holdings After Transaction: Common Stock — 18,538,150 shares (Direct)

Footnotes (2)

1. F1. On July 30, 2026, the issuer entered into a subscription agreement with the reporting person for a $1,000,000 investment in the issuer.
2. F2. The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

Key Figures

Shares purchased: 1,449,275 shares Purchase price per share: $0.69 Investment amount: $1,000,000 +1 more

4 metrics

Shares purchased 1,449,275 shares Common Stock acquired by Thomas Kosasa on July 30, 2026

Purchase price per share $0.69 Price per share for the July 30, 2026 subscription transaction

Investment amount $1,000,000 Subscription agreement investment by Thomas Kosasa in OneMedNet

Shares owned after transaction 18,538,150 shares Direct OneMedNet common stock holdings following the purchase

Key Terms

subscription agreement, volume-weighted average price (VWAP), reporting person

3 terms

subscription agreement financial

"entered into a subscription agreement with the reporting person for a $1,000,000 investment"

A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.

volume-weighted average price (VWAP) financial

"valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days"

Volume-weighted average price (VWAP) is the average price of a security over a trading period where each trade’s price is weighted by how many shares were traded, so larger trades pull the average more than tiny ones. Investors and traders use VWAP as a benchmark to judge whether a trade was executed at a favorable price—similar to checking whether you paid more or less than the typical price when most people were buying or selling.

reporting person regulatory

"subscription agreement with the reporting person for a $1,000,000 investment in the issuer"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/07/2026 - 05:22 PM Accepted by SEC EDGAR 08/07/2026 - 05:20 PM Learn about SEC filing dates

FAQ

What insider transaction did OneMedNet (ONMD) disclose involving Thomas Kosasa?

OneMedNet disclosed that director and 10% owner Thomas Kosasa purchased 1,449,275 shares of common stock on July 30, 2026. The transaction was executed via a $1,000,000 subscription agreement with the company, rather than a routine open-market trade.

How many OneMedNet (ONMD) shares did Thomas Kosasa buy and at what price?

Thomas Kosasa bought 1,449,275 OneMedNet common shares at $0.69 per share. The price was based on the volume-weighted average price (VWAP) of the stock over the 10 trading days immediately before the purchase date, according to the footnotes.

What was the total investment amount by Thomas Kosasa in ONMD in this transaction?

In this transaction, Thomas Kosasa invested $1,000,000 in OneMedNet Corp under a subscription agreement. The company stated that the investment was exchanged for 1,449,275 common shares, valued using the 10-day VWAP immediately preceding the July 30, 2026 purchase.

How many OneMedNet (ONMD) shares does Thomas Kosasa own after the purchase?

After the reported purchase, Thomas Kosasa directly owns 18,538,150 shares of OneMedNet common stock. This figure reflects his holdings immediately following the July 30, 2026 subscription transaction, as reported in the ownership column of the Form 4 data.

How was the purchase price for ONMD shares determined in Kosasa’s transaction?

The purchase price of $0.69 per OneMedNet share was determined using the volume-weighted average price (VWAP) for the 10 trading days immediately before the July 30, 2026 purchase, as described in the transaction footnotes to the filing.

Was the OneMedNet (ONMD) insider purchase structured as a subscription agreement?

Yes. OneMedNet stated that on July 30, 2026 it entered into a subscription agreement with Thomas Kosasa for a $1,000,000 investment. In exchange, he received 1,449,275 common shares priced using the 10-day VWAP prior to the purchase date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kosasa Thomas

(Last) (First) (Middle)

6385 OLD SHADY OAK ROAD, SUITE 250

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OneMedNet Corp [ ONMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/30/2026		P(1)		1,449,275	A	$0.69(2)	18,538,150	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On July 30, 2026, the issuer entered into a subscription agreement with the reporting person for a $1,000,000 investment in the issuer.

2. The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

	/s/ Robert Golden, Attorney-in-Fact	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)